These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5302115)

  • 21. [Significance of the cephalin-kaolin coagulation time in surgical odontology].
    Vialatel C; Richard JP
    Rev Odontostomatol (Paris); 1976; 5(5):341-4. PubMed ID: 1087449
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage.
    Furmaniak-Kazmierczak E; Cooke TD; Manuel R; Scudamore A; Hoogendorn H; Giles AR; Nesheim M
    J Clin Invest; 1994 Aug; 94(2):472-80. PubMed ID: 8040300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of the dental patient on anticoagulant medication.
    Rada RE
    Dent Today; 2006 Aug; 25(8):58-63. PubMed ID: 16925162
    [No Abstract]   [Full Text] [Related]  

  • 24. The procoagulant in human urine: purification, assay and some biochemical and physiological properties.
    Aoki N; Von Kaulla KN
    Thromb Diath Haemorrh; 1966 Dec; 16(3):586-605. PubMed ID: 5996676
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 26. [Intraperitoneal administration of fibrinolysin and blood coagulation].
    Zhenchevskiĭ RA
    Sov Med; 1969 Dec; 32(12):32-6. PubMed ID: 4246577
    [No Abstract]   [Full Text] [Related]  

  • 27. [Metabolism of I131-fibrinogen following intravenous and intraperitoneal administration after thrombin loading and blood loss].
    Tsushko VS
    Vopr Med Khim; 1980; 26(2):227-32. PubMed ID: 7456352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
    Goldschmidt B
    Acta Paediatr Acad Sci Hung; 1970; 11(2):135-9. PubMed ID: 5504583
    [No Abstract]   [Full Text] [Related]  

  • 29. On the role of vasoactive substances in haemodynamic changes induced by thrombin.
    Swedenborg J
    Acta Chir Scand; 1971; ():1-20. PubMed ID: 5556381
    [No Abstract]   [Full Text] [Related]  

  • 30. [Experience in the surgical-stomatological treatment of patients taking anticoagulants].
    Wagner U
    Stomatol DDR; 1976 Apr; 26(4):252-5. PubMed ID: 785709
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical pharmacology].
    Nava Rivera A
    ADM; 1964; 21(2):125-8. PubMed ID: 4177808
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticoagulant activity of the novel thrombin inhibitor 1-butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl) amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride.
    Okayama T; Araki S; Miyamae T; Morita Y; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Sep; 47(9):1023-6. PubMed ID: 9342415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of thymalin on blood coagulation and fibrinolysis].
    Kuznik BI; Budazhapova DTs; Zagrebina LA; Morozov VG; Khavinson VKh
    Farmakol Toksikol; 1981; 44(4):422-5. PubMed ID: 7286199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The great hemorrhagic diatheses].
    Paccalin J
    Rev Odontostomatol Midi Fr; 1969; 27(1):58-74. PubMed ID: 5307880
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of clotting inhibitive chronic dose of phenprocoumon on the prothrombin level and various enzymes of the rat].
    Stresemann E; Ast D
    Arzneimittelforschung; 1971 Jan; 21(1):145. PubMed ID: 5108379
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coagulative influence of 5-oxo-6-amino-7-ketimino-6-phenyldibenzo(a.c)cycloheptan].
    Milosev M; Aleksiev B; Nikolova M; Angelova O
    Pharmazie; 1972 Aug; 27(8):520-1. PubMed ID: 5084571
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of clenbuterol on haemocoagulation process in calves.
    Domina F; Niutta PP; Naccari C; Pugliese A; Naccari F
    J Vet Med A Physiol Pathol Clin Med; 2005 Mar; 52(2):53-4. PubMed ID: 15737171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective effect of malathion on blood coagulation versus locomotor activity.
    Sweeney MI; Lyon ME
    J Environ Pathol Toxicol Oncol; 1999; 18(3):203-11. PubMed ID: 15281233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of thrombin and adrenaline for the development of secondary anticoagulation system (SAC) in experimental animals].
    Kudrjashov BA; Ljapina LA; Kovaleva TN
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):76-84. PubMed ID: 4121133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.